Regeneron and Sanofi cut Praluent price, matching Amgen move- STAT

Regeneron and Sanofi cut Praluent price, matching Amgen move- STAT

STAT Plus: Regeneron and Sanofi cut Praluent price 60 percent, as low-selling cholesterol drugs become a drug pricing laboratory

By MATTHEW HERPER

RICK GERSHON/GETTY IMAGES

Regeneron and Sanofi will cut the price of their cholesterol drug Praluent by 60 percent to $5,850 a year.

READ MORE